43

KeY Figures

6,000 ward consultations/year Expertise in 20 environmental and food control procedures in collaboration with specialised laboratories

6 staff members

INFECTIOUS DISEASES MEDICINE

FielD, technologies anD MethoDs

Infection control is mandatory in hospitals in order to prevent, control and decrease the incidence of nosocomial infections.

Standard environmental controls include sampling air to detect Aspergillus conidia in critical areas such as the sterile and intensive care units, and sampling water to detect Legionella. In the event of nosocomial infection, patients are isolated to prevent further contamination. A daily tour of all wards, and visits to all patients receiving antibiotics who have infections or are febrile, contribute to improving the management of infectious complications.

In collaboration with other specialized units, protective measures, vaccination programmes and antimicrobial prophylaxis with antibacterial and antifungal agents are implemented when and where needed, in accordance with various risk factors.

Management of febrile neutropaenia is a main concern. With a view towards preserving the best possible quality of life, low risk patients are provided with oral antibiotics and followed up as out-patients until the febrile neutropaenic episode has been resolved.

Intensive research is carried out on preventing and managing invasive fungal infections. In collaboration with the pharmaceutical industry, the Unit participates in studies to evaluate new antifungal drugs.

Dr Angela Loizidou Internist

Dr Michael Aoun Internist, Head of Unit

Catheline Devleeshouwer Infection Control Nurse

Missions Preventing and treating infectious complications

Carrying out clinical research

DePartMental organisation The Infectious Diseases Unit comprises 1 head physician, 2 assistant physicians, 1 research nurse, 2 nurses specialising in infection control and a secretary. The team is available 7 days a week/24 hours a day to provide assistance with any infectious problem or alert that arises in the hospital and, on a daily basis, visits patients affected by infectious complications. The team is responsible for the monitoring and reporting of infections acquired by patients while in hospital (nosocomial infections). The Unit is a key member of the Institute’s Hygiene Committee and works closely with the Microbiology Laboratory. It takes part in the multidisciplinary meetings as required.

Advances in the use of cancer therapeutic agents in parallel with antimicrobial prevention and treatment of infectious complications can give years, if not decades, of productive life to many cancer patients. Dr MiCHAeL AOun, Head of the infectious Diseases unit